Work

Abstract OT3-2-07: Phase I study of ARN-810, a novel selective estrogen receptor degrader, in post-menopausal women with locally advanced or metastatic estrogen receptor positive breast cancer

Year: 2013

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/0008-5472.sabcs13-ot3-2-07

Authors: IA Mayer, A Bardia, MN Dickler, HC Manning, U Mahmood, GA Ulaner, JH Hager, P Rix, N Zack, EC Maneval, I Chen, J Baselga, CL Arteaga

Institutions: Memorial Sloan Kettering Cancer Center, Massachusetts General Hospital, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1991745909

Cites:

Cited by: 11

Related to: 10